(Q34103026)

31 July 2017

title

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL. (English)

1 reference

31 July 2017

1 reference

Babaian RJ

1

1 reference

31 July 2017

Fritsche H

2

1 reference

31 July 2017

Ayala A

3

1 reference

31 July 2017

Bhadkamkar V

4

1 reference

31 July 2017

Johnston DA

5

1 reference

31 July 2017

Naccarato W

6

1 reference

31 July 2017

Zhang Z

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

56

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1000-1006

1 reference

Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Evaluation of prostAsure index in the detection of prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

The national survey of prostate cancer in the United States by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Role of PSA and its indices in determining the need for repeat prostate biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900830-X

7 January 2021

10.1016/S0090-4295(00)00830-X

Identifiers

DOI

1 reference

31 July 2017

1 reference